Nimodipine, a dihydropyridine-type calcium channel blocker, prevents alcoholic hepatitis caused by chronic intragastric ethanol exposure in the rat

Hepatology

Volumn 24, Issue 2, 1996, Pages 391-397

  Iimuro, Yuji ^a   Ikejima, Kenichi ^a   Rose, Michelle L ^a   Bradford, Blair U ^a   Thurman, Ronald G ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ASPARTATE AMINOTRANSFERASE; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; LIPOPOLYSACCHARIDE; NIMODIPINE; OXYGEN;

ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ALCOHOL METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CALCIUM CELL LEVEL; CONTROLLED STUDY; FATTY LIVER; INFLAMMATION; LIVER NECROSIS; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RAT;

EID: 0029778880     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v24.pm0008690410     Document Type: Article

References (51)

1. Lelbach WK. Liver damage in chronic alcoholism. Results of a clinical, clinical-chemical and bioptic-histological study in 526 alcoholic patients during a low calorie diet in an open drinking sanatorium. Acta Hepatosplenol 1966;13:321-349.
2. Tsukamoto H, Reiderberger RD, French SW, Largman C. Long-term cannulation model for blood sampling and intragastric infusion in the rat. Am J Physiol 1984;247:R595-R599.
3. French SW, Miyamoto K, Tsukamoto H. Ethanol-induced hepatic fibrosis in the rat: role of the amount of dietary fat. Alcohol Clin Exp Res 1986; 10:13S-19S.
4. Lieber CS, DeCarli LM. Animal models of chronic ethanol toxicity. Methods Enzymol 1994;233:585-594.
5. Adachi Y, Bradford BU, Gao W, Bojes HK, Thurman RG. Inactivation of Kupffer cells prevents early alcohol-induced liver injury. HEPATOLOGY 1994;20:453-460.
6. Knecht KT, Adachi Y, Bradford BU, Iimuro Y, Kadiiska M, Qun-hui X, Thurman RG. Free radical adducts in the bile of rats treated chronically with intragastric alcohol: inhibition by destruction of Kupffer cells. Mol Pharmacol 1995;47:1028-1034.
7. Adachi Y, Moore LE, Bradford BU, Gao W, Thurman RG. Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology 1995;108:218-224.
8. Laskin DL. Nonparenchymal cells and hepatotoxicity. Semin Liver Dis 1990;10:293-304.
9. Decker K. Biologically active products of stimulated liver macrophages (Kupffer cells). Eur J Biochem 1990;192:245-261.
10. Chao W, Siafaka-Kapadai A, Olson MS, Hanahan DJ. Biosynthesis of platelet-activating factor by cultured rat Kupffer cells stimulated with calcium ionophore A23187. Biochem J 1989; 257:823-829.
11. Takei Y, Marzi I, Kauffman FC, Currin RT, Lemasters JJ, Thurman RG. Prevention of early graft failure by the calcium channel blocker nisoldipine: involvement of Kupffer cells. Transplantation 1990;50:14-20.
12. Peck RG, Lefer AM. Protective effects of nifedipine in the hypoxic perfused cat liver. Agents and Actions 1981;11:119-126.
13. Thurman RG, King J, Lemasters JJ. Nitrendipine protects the liver against hypoxia-induced damage at submicromolar concentrations in the perfused rat liver. J Cardiovasc Pharmacol 1987;9:S71-S76.
14. Hijioka T, Rosenberg RL, Lemasters JJ, Thurman RG. Rat Kupffer cells contain voltage-dependent calcium channels. Mol Pharmacol 1991;41:435-440.
15. Goto M, Lemasters JJ, Thurman RG. Activation of voltage-dependent calcium channels in Kupffer cells by chronic treatment with alcohol in the rat. J Pharmacol Exp Ther 1993;267:1264-1268.
16. Kazda S, Towart R. Nimodipine: a new calcium antagonistic drug with a preferential cerebrovascular action. Acta Neurochir 1982;63:259-265.
17. Altamura AC, Regazzetti MG, Porta M. Nimodipine in human alcohol withdrawal syndrome - an open study. Eur Neuropsychopharmacol 1990; 1:37-40.
18. Thompson JA, Reitz RC. Effects of ethanol ingestion and dietary fat levels on mitochondrial lipids in male and female rats. Lipids 1987;13:540-550.
19. Badger TM, Crouch J, Irby D, Shahare M. Episodic excretion of ethanol during chronic intragastric ethanol infusion in the male rat: continuous vs. cyclic ethanol and nutrient infusions. J Pharmacol Exp Ther 1993; 264: 938-943.
20. Bergmeyer HU. Methods of Enzymatic Analysis. New York: Academic Press, 1963:285-289, 837-845.
21. Nanji AA, Mendenhall CL, French SW. Beef fat prevents alcoholic liver disease in the rat. Alcohol Clin Exp Res 1989;13:15-19.
22. Scholz R. Hemoglobin-free perfusion of isolated rat liver. In: Staib W, Scholz R, eds.) Stoffwechsel der perfundierten leber. Berlin: Springer-Verlag; 1968:24-34.
23. Pertoft H, Smedsrod B. Separation and characterization of liver cells. In: Pretlow TGII, Pretlow TP. Cell separation: methods and selected applications. New York, NY: Academic Press; 1987;4:1-24.
24. Doolittle M, Bohman R, Durstenfeld A, Cascarano J. Identification and characterization of liver nonparenchymal cells by flow cytometry. HEPATOLOGY 1987;7:696-703.
25. Sahn AK, McCarthy KD. Norepinephrine-evoked calcium transients in cultured cerebral type I astroglia. Glia 1990;3:529-538.
26. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985;260: 3440-3450.
27. Ratto GM, Payne R, Owen WG, Tsien RY. The concentration of cytosolic free calcium in vertebrae rod outer segments measured with fura-2. J Neurosci 1988;8:3240-3246.
28. Tsukamoto H, French SW, Reidelberger RD, Largman C. Cyclical pattern of blood alcohol levels during continuous intragastric ethanol infusion in rats. Alcohol Clin Exp Res 1985;9:31-37.
29. Yuki T, Thurman RG. The swift increase in alcohol metabolism. Time course for the increase in hepatic oxygen uptake and the involvement of glycolysis. Biochem J 1980;186:119-126.
30. Landon EJ, Naukam RJ, Sastry BVR. Effects of calcium channel blocking agents on calcium and centrilobular necrosis in the liver of rats treated with hepatotoxic agents. Biochem Pharmacol 1986;35:697-705.
31. Thurman RG, Apel E, Badr M, Lemasters JL. Protection of liver by calcium entry blockers. Ann NY Acad Sci 1988;522:757-770.
32. Bode JC, Bode C, Heidelbach R, Durr H-K, Martini GA. Jejunal microflora in patients with chronic alcohol abuse. Hepatogastroenterology 1984;31: 30-34.
33. Bode JC. Alcohol and the gastrointestinal tract. In: Frick HP, Harnack GA, Martini GA, Prader A, eds. Advances in internal medicine and pediatrics. Heidelberg: Springer-Verlag, 1980:1-75.
34. Arai M. Effect of ethanol on the intestinal uptake of endotoxin. Nippon Shokakibyo Gakkai Zasshi 1986;83:1060.
35. 2. Am J Pathol 1993;142:367-373.
36. Nanji AA, Khettry U, Sadrzadeh SMH. Lactobacillus feeding reduces endotoxemic alcoholic liver disease. Proc Soc Exp Biol Med 1994;205:243-247.
37. Videla L, Bernstein J, Israel Y. Metabolic alteration produced in the liver by chronic alcohol administration. Increased oxidative capacity. Biochem J 1973;134:507-514.
38. Bernstein J, Videla L, Israel Y. Metabolic alterations produced in the liver by chronic ethanol administration. Changes related to energetic parameters of the cell. Biochem J 1973;134:515-521.
39. Ji S, Lemasters JJ, Christenson VR, Thurman RG. Periportal and pericentral pyridine nucleotide fluorescence from the surface of the perfused liver: evaluation of the hypothesis that chronic treatment with ethanol produces pericentral hypoxia. Proc Natl Acad Sci U S A 1982;79:5415-5419.
40. Arteel GE, Raleigh JA, Thurman RG. The swift increase in alcohol metabolism (SIAM) causes hypoxia in rat liver in vivo: assessment with the 2-nitroimidazole hypoxia marker, pimonidazole. Am J Physiol 1996; in press.
41. Bradford BU, Misra UK, Thurman RG. Kupffer cells are required for the swift increase in alcohol metabolism. Res Commun Subst Abuse 1993;14: 1-6.
42. 2 consumption: effect of alcohol treatment on cell-cell communication. Am J Physiol 1996;270:G574-G580.
43. 2+ requirement of prostanoid but not of superoxide production by rat Kupffer cells. Eur J Biochem 1988; 177:61-67.
44. Savier E, Shedlofsky SI, Swim AT, Lemasters JJ, Thurman RG. The calcium channel blocker nisoldipine minimizes the release of tumor necrosis factor and interleukin-6 following rat liver transplantation. Transpl Int 1992;5:S398-S402.
45. Oide H, Thurman RG. Hepatic Ito cells contain calcium channels: increases with transforming growth factor-β1. HEPATOLOGY 1994;20:1009-1014.
46. Kawada N, Klein H, Decker K. Eicosanoid-mediated contractility of hepatic stellate cells. Biochem J 1992;285:367-371.
47. Pinzani M, Failli P, Ruocco C. Fat-storing cells as liver-specific pericytes: spatial dynamics of agonist-stimulated intracellular calcium transients. J Clin Invest 1992;90:642-646.
48. Diehl AM. Alcoholic liver disease. Med Clin North Am 1989;73:815-830.
49. Nolan JP. Endotoxin, reticulo-endothelial function, and liver injury. HEPATOLOGY 1981;1:458-465.
50. Iimuro Y, Yamamoto M, Kohno H, Itakura J, Fujii H, Matsumoto Y. Blockade of liver macrophages by gadolinium chloride reduces lethality in endotoxemic rats: analysis of mechanisms of lethality in endotoxemia. J Leukoc Biol 1994;55:723-728.
51. Iimuro Y, Yamamoto M, Inoue S, Itakura J, Tsunoda M, Matsumoto Y. Improved survival rates with gadolinium chloride in an endotoxin shock model in the rat. Shoukaki to Meneki 1992:186-191.